A clinical oncology department prepares a syringe containing a therapeutic mixture of two radionuclides, X and Y, used for targeted brachytherapy. The mixture is housed in a thin plastic syringe.
The properties of these two radionuclides are as follows:
The syringe has the same number of nuclei of X and Y at the start.
State and explain which radionuclide has the greatest activity at the start.
State why it is dangerous for the clinical researcher to handle the plastic syringe with bare hands.
Helium-3 (23He^{3}_{2}\text{He}23He) is produced in a fusion reactor when Deuterium (12H^{2}_{1}\text{H}12H) nuclei fuse. The nuclear reaction equation is:
12H+12H→23He+W ^{2}_{1}\text{H} + ^{2}_{1}\text{H} \rightarrow ^{3}_{2}\text{He} + \text{W} 12H+12H→23He+WState the proton number of particle W\text{W}W.
Use the data below to determine the binding energy per nucleon of the 23He^{3}_{2}\text{He}23He nucleus. Write your answer to 3 significant figures.